Option Care Health, Inc. (OPCH)
Nasdaq · Healthcare · Medical Care Facilities
$23.37+3.22%as of Oct 6, 2026, 1:35 AM ET
- Market cap
- $3.5B
- P/E (trailing)
- 17.7
- Forward P/E
- 11.2
- 52-week range
- $18.01 – $36.80
- 52-week change
- −17.16%
- EPS (trailing)
- $1.32
- Next earnings
- Oct 29, 2026
Fiscal year to Dec 2025
- Revenue
- $5.6B (+13.03%)
- Net income
- $208M
- Operating margin
- 6.0%
- Diluted EPS
- $1.27
- Free cash flow
- $217M
From the company’s annual report on SEC EDGAR.
About Option Care Health, Inc.
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failure; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as Duchenne muscular dystrophy, multiple sclerosis, Alzheimer's disease, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services.
Headquarters: Bannockburn, United States · 8,000 employees · optioncarehealth.com